KOD Latest Press Releases

-- August 13, 2026 --

Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2026 Financial Results PRNewswire 4:00 PM

-- August 10, 2026 --

Kodiak Sciences Announces First Patients Enrolled in Global Phase 3 ALTO trial of KSI-501 in Patients with Diabetic Macular Edema PRNewswire 4:44 PM

-- August 6, 2026 --

Kodiak Sciences Completes Enrollment in First Pivotal Cohort in the Phase 3 PEAK Trial of KSI-101 for Macular Edema Secondary to Inflammation and Reaffirms Topline Clinical Data Release Remains on Track for December 2026 PRNewswire 7:00 AM

-- May 28, 2026 --

Kodiak Sciences to Present at 2026 Jefferies Global Healthcare Conference PRNewswire 6:10 PM

-- May 7, 2026 --

Kodiak Sciences Announces Recent Business Highlights and First Quarter 2026 Financial Results PRNewswire 4:00 PM

-- May 1, 2026 --

Kodiak Sciences to Present Pipeline Advances and KSI-101 Clinical Data, Including Results from a MESI Cohort in a Tertiary Care Uveitis Practice, at Upcoming Scientific Conferences PRNewswire 12:23 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software